Mark Purcell analyst MORGAN STANLEY

Currently out of the existing stock ratings of Mark Purcell, 26 are a HOLD (44.83%), 11 are a SELL (18.97%), 21 are a BUY (36.21%).

Mark Purcell

Work Performance Price Targets & Ratings Chart

Analyst Mark Purcell works at MORGAN STANLEY with a stock forecast success ratio of 32.86% fulfilled within 184.6 days on average.

Mark Purcell’s has documented 113 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 23-Jan-2024.

Wall Street Analyst Mark Purcell

Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 1/23/2024. The price target of $120 was fulfilled within 17 days with a profit of $14.63 (13.88%) receiving and performance score of 8.17.

Average potential price target upside

AZN AstraZeneca PLC ADR GSK GlaxoSmithKline PLC ADR NVS Novartis AG ADR NVO Novo Nordisk A/S SNY Sanofi ADR RHHBY Roche Holding Ltd ADR

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

80

$9.87 (14.07%)

83

2 months 11 days ago

0/3 (0%)

$19.52 (32.28%)

Buy

85

$14.87 (21.20%)

3 months ago

0/11 (0%)

$19.26 (29.30%)

Hold

70

$-0.13 (-0.19%)

3 months 20 days ago

5/5 (100%)

$2.71 (4.03%)

224

Buy

142.74

9 months 11 days ago

0/6 (0%)

$75.62 (112.66%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Mark Purcell is most bullish on?

Potential upside of $18.88 has been obtained for NVS (NOVARTIS AG ADR)

Which stock is Mark Purcell is most reserved on?

Potential downside of -$5.26 has been obtained for NVO (NOVO NORDISK A/S)

What Year was the first public recommendation made by Mark Purcell?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?